Cargando…

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsolini, Laura, Chiappini, Stefania, Volpe, Umberto, De Berardis, Domenico, Latini, Roberto, Papanti, Gabriele Duccio, Corkery, John Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/ https://www.ncbi.nlm.nih.gov/pubmed/31450833 http://dx.doi.org/10.3390/medicina55090525

Ejemplares similares

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
por: Orsolini, Laura, et al.
Publicado: (2019)

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports
por: Orsolini, Laura, et al.
Publicado: (2020)

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2017)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse
por: Orsolini, Laura, et al.
Publicado: (2021)

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
por: Orsolini, Laura, et al.
Publicado: (2017)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
por: Chiappini, Stefania, et al.
Publicado: (2023)

The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
por: Cohen, Koby, et al.
Publicado: (2018)

MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
por: Riaz, Kainat, et al.
Publicado: (2023)

Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017)

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis
por: Mensen, Vincent T., et al.
Publicado: (2019)

The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review
por: Takakuwa, Kevin M., et al.
Publicado: (2021)

Medical cannabis use among patients with Post-Traumatic Stress Disorder (PTSD): A nationwide database study
por: Yakirevich Amir, N., et al.
Publicado: (2023)

Suicidality in post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD)
por: Longo, L., et al.
Publicado: (2021)

Introduction to Cannabis and Cannabinoid Research
por: Piomelli, Daniele
Publicado: (2016)

The nephrologist's guide to cannabis and cannabinoids
por: Rein, Joshua L.
Publicado: (2020)

Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
por: Abrams, Donald I.
Publicado: (2022)

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online
por: Zangani, Caroline, et al.
Publicado: (2020)

Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence
por: Schulze-Schiappacasse, Clara, et al.
Publicado: (2022)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis
por: Reece, Albert Stuart, et al.
Publicado: (2022)

Research Progress on Cannabinoids in Cannabis (Cannabis sativa L.) in China
por: Sun, Xiangping
Publicado: (2023)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
por: Gonen, Tal, et al.
Publicado: (2020)

Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis
por: Radwan, Mohamed M., et al.
Publicado: (2021)

Use of Cannabis and Cannabinoids for Treatment of Cancer
por: Cherkasova, Viktoriia, et al.
Publicado: (2022)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

Cannabis in the management of PTSD: a systematic review
por: Rehman, Yasir, et al.
Publicado: (2021)

Medical cannabis for treatment-resistant combat PTSD
por: Nacasch, Nitsa, et al.
Publicado: (2023)

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
por: Craft, Sam, et al.
Publicado: (2021)

Development and Validation of the LC–MS/MS Method for Determination of 130 Natural and Synthetic Cannabinoids in Cannabis Oil
por: Galant, Natalia, et al.
Publicado: (2022)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Medicinal use of cannabis based products and cannabinoids
por: Freeman, Tom P, et al.
Publicado: (2019)

Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy
por: Zaiachuk, Mariia, et al.
Publicado: (2021)

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids
por: Raup-Konsavage, Wesley M.
Publicado: (2023)

Editorial: “No Words for Feelings, Yet!” Exploring Alexithymia, Disorder of Affect Regulation, and the “Mind-Body” Connection
por: De Berardis, Domenico, et al.
Publicado: (2020)

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3qp5gqu1nv7rg8a4m2ffar1n3